News and Events

Ms. Zhu Zhou has passed her Ph.D. thesis Oral examination on Parkinson’s disease (PD) treating drug, CB6

January 04, 2022

Prof. Li Min’s research postgraduate student Ms. Zhu Zhou from Mr. & Mrs. Ko Chi Ming Centre for Parkinson's Disease Research has passed her Ph.D. thesis Oral examination on 20 December 2021. She has done astounding research work on the autophagy-inducing mechanism and anti-Parkinsonian effects of a Chinese medicine compound Corynoxine B (Cory B) analogue CB6. Previously, Prof. Li Min’s research team has identified Cory B as a neuronal autophagy activator, but its brain permeability is relatively low. A Corynoxine B analogue with better bioavailability termed CB6 was newly synthesized. Ms. Zhu Zhou, in her Ph.D. dissertation work, has ascertained the autophagy-inducing and anti-PD activity of CB6 in in vitro and in vivo experimental models. This work has been published in the peer-reviewed journal Acta Pharmacologica Sinica. The research team is looking forward to developing this compound further as a clinically competitive therapeutic agent for treating PD patients.

1641279716597900 1641279716597900
Ms. ZHU Zhou and oral examination board members (Top row: Left to right): Dr. SONG You-Qiang, Associate Professor, School of the School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong; Prof. CHEN Hubiao, Professor, School of Chinese Medicine, Hong Kong Baptist University; Dr. LIU Jin, Assistant Professor, School of Chinese Medicine, Hong Kong Baptist University. (Middle row: Left to right): Prof. YU Zhiling, Professor, School of Chinese Medicine, Hong Kong Baptist University; Prof. LI Min, Sravan’s principal supervisor, Associate Dean, School of Chinese Medicine, Hong Kong Baptist University; Prof. SHEN Hanming, Chair Professor, Faculty of Health Sciences, University of Macau. (Bottom row): Ms. ZHU Zhou.